stars 1 stars 2 stars 3

Marginum is pioneering fluorescence-based optical tissue monitoring technologies for oncological surgery. Its data-driven solutions enable safe and efficient monitoring of tumour tissues during cancer surgery without compromising pre-existing surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure the seamless clinical compatibility of its technological solutions.

Marginum Questions

Samu Lehtonen is the CEO and Co-Founder of Marginum.

7 people are employed at Marginum.

Top Marginum Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users